U.S. FDA APPROVES JASCAYD (nerandomilast) for PPF!

Hope is strong, action is stronger.

FDA PRESS RELEASE: “FDA approves drug to treat idiopathic pulmonary fibrosis” (10/7/2025)

BOEHRINGER INGELHEIM PRESS RELEASE: “U.S. FDA approves JASCAYD (nerandomilast) tablets for the treatment of progressive pulmonary fibrosis in adults” (12/19/2025)